Charlie Gard, a British baby who became the subject of a bitter dispute between his parents and doctors over whether he should be taken to the United States for experimental treatment, has died, local media said on Friday.
The 11-month-old baby suffered from an extremely rare genetic condition causing progressive brain damage and muscle weakness, and his parents’ long struggle to save him drew an international outpouring of sympathy, including from U.S. President Donald Trump and Pope Francis.
“Our beautiful little boy has gone, we are so proud of you Charlie,” Connie Yates, the baby’s mother, was quoted as saying by the Daily Mail.
Great Ormond Street Hospital, where Charlie had been receiving treatment, had no immediate comment on the Daily Mail report. Local media said a family spokesman had confirmed the death.
After a harrowing legal battle that prompted a global debate over who has the moral right to decide the fate of a sick child, a judge on Thursday ordered that Charlie be moved to a hospice where the ventilator that keeps him alive would be turned off.
Charlie required a ventilator to breathe and was unable to see, hear or swallow.
The case drew comment from Trump, who tweeted on July 3 that “we would be delighted” to help Charlie, and from Pope Francis, who called for the parents to be allowed to do everything possible to treat their child.
Britain’s courts, after hearing a wealth of medical evidence, ruled that it would go against Charlie’s best interests to have the experimental nucleoside therapy advocated by a U.S. professor of neurology, Michio Hirano.
U.S. Vice President Mike Pence tweeted that he was saddened to hear of Charlie’s death. He has previously referred to the case in the context of the U.S. healthcare debate, saying it offered a warning of the risks of state-funded healthcare.